TRANSCEND-XR Co-creation and implementation of an intervention to improve the understanding of TesticulaR cANcer late effects and unmet Supportive CarENeeDs of AYA survivors using eXtended Reality.
- Coordinator
- University College Cork - National University of Ireland, Cork, Ireland
- Runs
- 1 June 2025 to 30 November 2030
- Status
- Running
- EU funding
- €6.0m
- Total cost
- €6.0m
- Partners
- 15 organisations in 11 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101214413
What the project is doing
In the project's own words, from its summary on CORDIS.
CHALLENGE: Adolescence and early adulthood are critical stages for development. A diagnosis of a life-threating disease like cancer in adolescents and young adults (AYAs), coupled with immediate and late effects of treatment, force AYAs to face mortality early in life. Testicular Cancer (TC) is the most diagnosed cancer in AYAs assigned male at birth aged 15-39 years. The incidence of TC has doubled over the last four decades, with highest incidence rates in individuals of European ancestry.
Interventions to educate and support AYA TC survivors, and reduce symptom burden and late effects of TC treatment should be prioritised. SOLUTION: Project TRANSCEND-XR will ethically co-create, test, and scale up in real-life settings an innovative digital intervention to increase AYA TC survivors’ knowledge of the late effects of TesticulaR cANcer treatment and address their unmet Supportive CarE NeeDs using eXtended Reality.
PLAN: TRANSCEND-XR will ensure that (i) the needs of AYA TC survivors, their care partners, and healthcare professionals are explored and disparities addressed
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| University College Cork - National University of Ireland, Cork | Cork | Ireland | Coordinator |
| Association Europeenne Des Ligues Contre Le Cancer ASBL | Bruxelles / Brussel | Belgium | Participant |
| Khora Aps | Kbenhavn V | Denmark | Participant |
| Predictby Research and Consulting S.l. | Barcelona | Spain | Participant |
| Institut Gustave Roussy | Villejuif | France | Participant |
| Sveuciliste U Zagrebu Medicinski Fakultet | Zagreb | Croatia | Participant |
| Fundtoinnovate Limited | Cork | Ireland | Participant |
| The Adelaide & Meath Hospital Dublin Incorporating the National Children's Hospital | Dublin | Ireland | Participant |
| Fondazione Irccs Istituto Nazionale Dei Tumori | Milan | Italy | Participant |
| Academisch Ziekenhuis Groningen | Groningen | Netherlands | Participant |
| Erasmus Universitair Medisch Centrum Rotterdam | Rotterdam | Netherlands | Participant |
| Universidade Catolica Portuguesa | Lisboa | Portugal | Participant |
| Univerzita Komenskeho V Bratislave | Bratislava 1 | Slovakia | Participant |
| The Queen's University of Belfast | Belfast | United Kingdom | Participant |
| The Royal Marsden National Health Service Trust | London | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI